{
  "symbol": "ABBV",
  "year": 2025,
  "period": "Q2",
  "curated_text": "Symbol: ABBV. Year: 2025. Period: Q2. ReportType: Q10. Section: Competition and Market Position. This section discusses competitors, market dynamics, and regulatory landscape.  Competitors mentioned: the California Business and Professions Code, the State of, Oregon Circuit Court, AndroGel, sham litigation, MDL, National Prescription Opiate Litigation, the United States Tax Court, AbbVie Inc., Subsidiaries, the Internal Revenue Service, Shareholder and Securities Litigation, Holwill, Humira, Camargo, Allergan Inc., the U.S. Patent Office, the United States Court of Appeals, the Ninth Circuit, Biocell\u00ae, Allergan Biocell Textured Breast Implant, Product Liability Litigation, Sheet Metal Workers\u2019 Health Plan of Southern California, Intellectual Property Litigation AbbVie Inc., Rinvoq, Hetero USA, Inc., Hetero Labs Limited Unit-V, Aurobindo Pharma Ltd., Sandoz, Inc., Sandoz Private Limited, Sun Pharmaceutical Industries, Ltd., Aurobindo Pharma U.S.A., Aurobindo Pharma Limited, Zydus Pharmaceuticals, Zydus Lifesciences Limited, MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, MSN Life Sciences Private Limited, Hetero USA Inc., Hetero Labs Limited Unit-III, Merck Sharp & Dohme, CODM, International 506 352 Total, International 377 499 Total, Neuroscience, Botox Therapeutic, International 7 6 Total, International 21 3 Total, Vyalev United, International 4 4 Total, Lumigan/Ganfort United States, ANALYSIS OF FINANCIAL CONDITION, the Condensed Consolidated Financial Statements, Supplementary Data, Research and Development Research, the European Commission, EC, GCA, the U.S. Food and Drug Administration, FDA, Biologics License Application, the U.S. FDA, BoNT, Emblaveo, aztreonam and avibactam, Percent, United States, Botox Therapeutic United, Juvederm Collection United, Linzess/Constella United, Vraylar, Ubrelvy, Imbruvica, Venclexta, Botox Cosmetic, Juvederm Collection, ImmunoGen, SG&A, Upfront, Non-Operating Expenses (Income, LIQUIDITY, Nimble Therapeutics, Inc., Cerevel Therapeutics, Credit Risk AbbVie. Context excerpt: competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the court dismissed on October 31, 2024. In March 2025, the court approved the parties\u2019 settlement of this matter. Government Proceedings Lawsuits are pending against Allergan and several other manufacturers generally alleging that they improperly promoted and sold prescription opioid products. Approximately 430 lawsuits are pending against Allergan in federal and state courts. Most of the federal court lawsuits are consolidated for pre-trial purposes in the United States District Court for the Northe",
  "competition_summary": [
    {
      "competitor": "the California Business and Professions Code",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "the State of",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Oregon Circuit Court",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "AndroGel",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "sham litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "MDL",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "National Prescription Opiate Litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "the United States Tax Court",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "AbbVie Inc.",
      "mentions": 3,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Subsidiaries",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "the Internal Revenue Service",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Shareholder and Securities Litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Holwill",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Humira",
      "mentions": 12,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Camargo",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Allergan Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "the U.S. Patent Office",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "the United States Court of Appeals",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "the Ninth Circuit",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Biocell\u00ae",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Allergan Biocell Textured Breast Implant",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Product Liability Litigation",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Sheet Metal Workers\u2019 Health Plan of Southern California",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Intellectual Property Litigation AbbVie Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Rinvoq",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Hetero USA, Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Hetero Labs Limited Unit-V",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Aurobindo Pharma Ltd.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Sandoz, Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Sandoz Private Limited",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Sun Pharmaceutical Industries, Ltd.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Aurobindo Pharma U.S.A.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Aurobindo Pharma Limited",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Zydus Pharmaceuticals",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Zydus Lifesciences Limited",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "MSN Pharmaceuticals Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "MSN Laboratories Private Limited",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "MSN Life Sciences Private Limited",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Hetero USA Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Hetero Labs Limited Unit-III",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Merck Sharp & Dohme",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "CODM",
      "mentions": 6,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "International 506 352 Total",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "International 377 499 Total",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Neuroscience",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Botox Therapeutic",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "International 7 6 Total",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "International 21 3 Total",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Vyalev United",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "International 4 4 Total",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Lumigan/Ganfort United States",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "ANALYSIS OF FINANCIAL CONDITION",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "the Condensed Consolidated Financial Statements",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Supplementary Data",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Research and Development Research",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "the European Commission",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "EC",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "GCA",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "the U.S. Food and Drug Administration",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "FDA",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Biologics License Application",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "the U.S. FDA",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "BoNT",
      "mentions": 2,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Emblaveo",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "aztreonam and avibactam",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Percent",
      "mentions": 3,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "United States",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Botox Therapeutic United",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Juvederm Collection United",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Linzess/Constella United",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Vraylar",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Ubrelvy",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Imbruvica",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Venclexta",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Botox Cosmetic",
      "mentions": 3,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Juvederm Collection",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "ImmunoGen",
      "mentions": 7,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "SG&A",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Upfront",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Non-Operating Expenses (Income",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "LIQUIDITY",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Nimble Therapeutics, Inc.",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Cerevel Therapeutics",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    },
    {
      "competitor": "Credit Risk AbbVie",
      "mentions": 1,
      "context": "competition provision of the California Business and Professions Code seeking injunctive relief, restitution, civil penalties and attorneys\u2019 fees. In November 2022, the State of Oregon filed a lawsuit in the Multnomah County, Oregon Circuit Court, alleging that 2011 patent litigation by Abbott with a generic company regarding AndroGel was sham litigation and the settlement of that litigation violated state antitrust law. Oregon also brought a claim under the Oregon False Claims Act, which the co"
    }
  ]
}